Why the Big Lie About Steve

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone OMO #25421
Why the Big Lie About Steve Bannon?

bannon.sized-770x415xt.jpg

All the existential rage of the defeated and humiliated elites is now focused against Steve Bannon -- the architect of Trump's victory, the media genius who won the battle with less than a fifth of the financial resources at Hillary Clinton's disposal.

I know Steve Bannon, and have had several long discussions with him about politics. Steve is fervently pro-Israel, and it is utterly ridiculous to suggest that he is anti-Semitic.

Other observant Jews who know Bannon -- for example, Joel Pollak -- attest to his support for Israel and his friendship for the Jewish people.

We have learned from the sewage-storm directed at Bannon that the Establishment plays dirty, and that the formerly Republican #NeverTrumpers aren't just misguided ideologues, but also yellow-bellied, gutter-crawling, backstabbing, bushwhacking liars. Hell hath no fury like a self-designated elite scorned.

They hate Steve Bannon because he beat them, fair and square, on the battlefield of social media. He is the president-elect's most effective general. Trump's enemies can't reverse the results of a national election, but they can try to cut the incoming president off from his popular base.

The charges against Steve Bannon are a tissue of lies without a modicum of merit.

Anyone can search the Breitbart Media archive for posts on Israel, Jews, and related topics, as I have, and determine that Steve Bannon's hugely successful media platform is 100% pro-Israel.

Not only that: Breitbart consistently reports on the dangers of anti-Semitism around the world.

Not a single article appeared in Breitbart.com during the past two years that could not have appeared in Israel Hayom, the leading Israeli daily.

But that is not what one hears from Ian Tuttle at National Review, who complains that "in May, Weekly Standard editor Bill Kristol was labeled a 'Renegade Jew.'"

He was, indeed -- but by another Jew, David Horowitz. Horowitz argued that Kristol had betrayed Jewish interests by trying to torpedo Trump -- a point Horowitz emphasizes here.

Tuttle knows this. But Tuttle chose to twist Horowitz's headline into its opposite.

Tuttle's colleague Jonah Goldberg also now inveighs against Bannon, but his post is too silly to quote.

Generously, Tuttle allows that Bannon is not Goebbels.

He isn't. But the Establishment (including the conservative Establishment) media drumbeat against Bannon takes its cue from Goebbels' doctrine of the Big Lie: repeat it often enough, and people will believe it -- no matter how absurd it is.

Trump Sticks with People Who Stuck by Him, Media Bewildered

NeverTrumper John Podhoretz penned an underhanded attack on Steve Bannon on the Commentary website yesterday. One has to read Podhoretz's attack a couple of times to appreciate how sleazy it is:

The key moral problem with Steve Bannon is that as the CEO of Andrew Breitbart’s namesake organization, he is an aider and abetter of foul extremist views, including anti-Semitic ones. He used the site to promote the alt-right, which has retailed anti-Semitism as well as general outright racism and white nationalism. The distinction may seem like a minor one, but it isn’t; the hatred Breitbart has channeled is too general for it to be singled out for its anti-Semitic content.

Note the construction of Podhoretz' sentence: Breitbart isn't anti-Semitic, but in some vague, unnamed way, Breitbart has facilitated anti-Semitism from the alt-Right (whatever that is).

The man is an embarrassment to the venerable Jewish monthly. It's time for Commentary to find a new editor.

These are facts about Breitbart's content: indisputable, accessible, and easy to verify. Anyone can enter the terms "Jews" or "Israel" and "site:www.breitbart.com" into the Google search engine and obtain everything that Breitbart has published on the subjects.

I just looked through roughly a thousand articles and found nothing but pro-Israel, pro-Jewish content that might well have appeared in Israel Hayom.

There is not a shred of evidence -- not a single article -- that supports Podhoretz's allegation that Bannon and Breitbart aid and abet anti-Semitic views.

In lieu of that evidence, the supposedly anti-Semitic David Horowitz piece has been cited dozens of times in the past 24 hours (including by the Times of Israel!).

Of course, one expects the Establishment media to lie at two hundred decibels. Yesterday's email blast from the usually staid Financial Times began:

Donald Trump has chosen Reince Priebus, the establishment head of the Republican National Committee, as his chief of staff, while naming Steve Bannon -- his campaign chair who ran Breitbart News, a website associated with the alt-right and white supremacists -- as his chief strategist and counsellor.

To claim that Breitbart is associated with white supremacists is a despicable lie. But the FT feels compelled to say such things, because polite opinion requires ritual anathemas of Trump.

The liberal Jewish website The Forward wrote:

Will Steve Bannon bring anti-Semitism into Trump's inner circle?

The reaction was quick and furious from Jews and anti-hate groups. The Anti-Defamation League, which stays out of partisan politics and vowed to seek to work with Trump after his election, denounced Bannon as "hostile to American values."

It is shameful that Jewish organizations would "cry wolf" on such an important topic, leveling unsupportable charges of anti-Semitism in pursuit of a patently political agenda.

"A world is collapsing before our eyes," tweeted France's ambassador to the United States as the returns came in early in the morning of Nov. 9. Yes, the "liberal world order" of elitist social engineering has come to an end. The Weekly Standard and Commentary have no more reason to publish than do the New York Times or The New Republic.

The world simply has moved away from them. And symbolizing their humiliation is one man who took on their vast media machine with seemingly insignificant resources, and won. They will stop at nothing to destroy him.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viatris Declares Quarterly Dividend Amid Acquisition Buzz

Updated Category News Views 79

A Dividend Declaration with a Side of Mergers Viatris, the healthcare giant operating on a global scale, has been making some noise recently. On the surface, it's another quarterly dividend—$0.12 per share, set to hit the pockets of shareholders on December 16. But there's a lot more cooking under the hood of this announcement that ticks just about every box for a...

Continue Reading
Verismo's SynKIR™-310 Shows Promise in Phase 1 Trials

Updated Category News Views 61

KIR-CAR: A Fresh Take on Cancer Treatment So, Verismo Therapeutics is at it again with their KIR-CAR platform. They're set to present interim data at this year's ASH Annual Meeting. To all those following B-cell non-Hodgkin Lymphoma (B-NHL) treatments, pay attention. SynKIR™-310, a CD19-targeted therapy, is showing some real promise. The science behind this is like...

Continue Reading
SAFE's New Website: Engineering Excellence and Faith

Updated Category News Views 94

A Bold Digital Step for SAFE Structure Designs Now here's a move worth watching. SAFE Structure Designs, that U.S.-rooted defense contractor with its fingers in a multitude of engineering pies, just rolled out a fresh new face on the web. This isn't merely an online facelift; it's a declaration of ambition and capabilities. They're showcasing eight specialized divisions...

Continue Reading
Aeon Lands $13.8M Contract for Zeus Missile System

Updated Category News Views 165

Aeon's Big Win: SOCOM Contract for Zeus Well look at that! Aeon Industrial Inc. just snagged a pretty penny with a $13.8 million contract from the U.S. Special Operations Command (SOCOM). It's not every day a company gets to modernize the arsenal for the big leagues. This year-long deal wants Aeon at their sharpest, enhancing and testing the Zeus Missile System, known for...

Continue Reading
IM Digital Garners 2026 Klaviyo Partner Accolade

Updated Category News Views 122

Award Shows IM Digital's CRM Mastery It's not every day that a consultancy makes waves in the tech ocean, but IM Digital just scored a big one by nabbing the 2026 Klaviyo Global Partner of the Year award. When you see those shiny accolades, it's a testament to much more than just fancy buzzwords—it's about real grit and customer victories. Why It Matters in the CRM...

Continue Reading
Fluence Energy Lawsuit: Investors Face Key Deadline

Updated Category News Views 50

Fluence Energy Under Fire Fluence Energy, Inc., ain't having the best of times, folks. If you've been keeping an eye on the stock ticker NASDAQ:FLNC, you probably felt the shiver when the news of a securities fraud class action lawsuit hit the wire. This ain't about some minor slip-up. These allegations are rocking the boat hard. What's at Stake for Investors? Here's the...

Continue Reading
Navigating Builder-Ready Land: Avoid Costly Pitfalls

Updated Category News Views 18

Understanding the 'Builder-Ready' Label The term 'builder-ready' isn't as straightforward as it seems, especially when you're eye-balling land listings in rural areas. Cindy Garvey, a rural land expert, breaks down the frequent pitfalls buyers encounter when this label gets tossed around without much scrutiny. Utility Access Misconceptions Think utility access is a given?...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 125

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Peabody's Q3 2026: Margins Climb Despite Net Loss

Updated Category News Views 26

Tough Quarters but Promising Margins Alright, Peabody's Q3 2026 isn't the most sunshine-filled report I've laid eyes on, but it's not all shadows either. Sure, they posted a net loss of $32.8 million, better than last year's $70.1 million drain. Admit it or not, that's improvement. And yet, the real gem here is those expanding margins gleaming despite the loss-heavy...

Continue Reading
NSING's Bluetooth Milestone: A Signal for Investors

Updated Category News Views 68

The Bluetooth Bonanza: NSING Technologies' Big Win Amidst the bustling lanes of the semiconductor sector, NSING Technologies just threw down a whopper of an announcement—over 250 million Bluetooth chips shipped, all well-knitted with Ceva's technology. This isn’t just another milestone; it's a clarion call for anyone keeping an eye on the evolving landscape of...

Continue Reading

Top 5 Most Recently Viewed Articles

TTM Technologies Celebrates Awards and Leadership in Electronics

Updated Category News Views 229

TTM Technologies Recognizes Excellence at IPC CEMAC Conference SANTA ANA, Calif. — TTM Technologies, Inc. (NASDAQ: TTMI), a recognized leader in manufacturing technology products, has recently announced a remarkable achievement. During the 2025 IPC China Electronics Manufacturing Annual Conference (CEMAC), two esteemed members of the TTM team received renowned awards...

Continue Reading
OneAmerica Financial Declares Enhanced Dividend Rate for 2026

Updated Category News Views 313

OneAmerica Financial Declares Enhanced Dividend Rate for 2026 A prominent name in insurance and financial services, OneAmerica Financial, has made a significant announcement regarding its dividend allocation for policyholders of American United Life Insurance Company. This year, the company declared a notable increase in the dividend interest rate, which has risen by 10...

Continue Reading
Projected Growth in Drug-Device Combination Products Market

Updated Category News Views 152

Insights into the Drug-Device Combination Products Market The global drug-device combination products market is experiencing significant growth. Recent projections suggest that it is set to reach an impressive USD 389.7 billion by 2033, with a robust compound annual growth rate (CAGR) of 9.3% from 2024 onwards. As the healthcare landscape evolves, these combination...

Continue Reading
IPSEN's Recent Share Buy-Back Highlights and Market Impact

Updated Category News Views 168

Understanding IPSEN's Share Buy-Back Program The recent share buy-back program by IPSEN represents a strategic move in financial management. By repurchasing shares from the market, IPSEN aims to enhance shareholder value and positively impact its stock performance. Transaction Summary from Late July to Early August This segment provides an overview of IPSEN's transactions...

Continue Reading
Intensity Therapeutics Unveils Executive Stock Options to Drive Growth

Updated Category News Views 60

Stock Options Granted to Key Executives Intensity Therapeutics, Inc., a prominent biotechnology firm focused on innovative biological products, has recently made headlines by granting stock options to its key executives. This strategic move is part of the company's broader employee incentive program designed to foster loyalty and motivation among its top tier. Details of...

Continue Reading